Search

Author/Creator Garralda Cabanas, E.

1. Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors. (October 2022)

Authors:
Dziadziuszko, R.; Garralda Cabanas, E.; Rojas, K.; Chelstowska, M.; Blaszkowska, M.; Dudziak, R.; Rzymski, T.; Angelosanto, N.; Littlewood, P.; Nogai, H.; Boni, V.; Lugowska, I.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search